Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN.c featured on The Market Herald after sucessful study

View:

Post by StockHawk1 on Sep 07, 2022 2:05pm

AGN.c featured on The Market Herald after sucessful study

The Market Herald recently featured Algernon Pharmaceuticals (AGN.c AGNPF) in 'The Power Play' after the biotech company reported positive drug study results.

Its Phase 2a Study evaluating its NP-120 for the treatment of idiopathic pulmonary fibrosis and chronic cough found statistically significant improvements in measures of cough.

The CEO of AGN Christopher J. Moreau, shares more details about these results and how they will positively impact the company here: https://pr.report/kxDignfG

AGN @ $6.45, MC $12.797M